• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普雷沃氏菌属和加德纳菌属与细菌性阴道病一线抗生素治疗失败相关。

Prevotella and Gardnerella Are Associated With Treatment Failure Following First-line Antibiotics for Bacterial Vaginosis.

机构信息

Central Clinical School, Monash University, Melbourne, Victoria, Australia.

Melbourne Sexual Health Centre, Alfred Hospital, Carlton, Victoria, Australia.

出版信息

J Infect Dis. 2023 Aug 31;228(5):646-656. doi: 10.1093/infdis/jiad261.

DOI:10.1093/infdis/jiad261
PMID:37427495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10469350/
Abstract

BACKGROUND

Bacterial vaginosis (BV) is a common vaginal dysbiosis that often recurs following first-line antibiotics. We investigated if vaginal microbiota composition was associated with BV recurrence.

METHODS

We analyzed samples and data from 121 women who participated in 3 published trials evaluating novel interventions for improving BV cure, including concurrent antibiotic treatment of regular sexual partners (RSPs). Women diagnosed with BV received first-line antibiotics and self-collected vaginal swabs pretreatment and the day after finishing antibiotics (immediately posttreatment). 16S rRNA gene sequencing was performed on vaginal samples. Logistic regression explored associations between BV recurrence and features of the vaginal microbiota pre- and posttreatment.

RESULTS

Sixteen women (13% [95% confidence interval {CI}, 8%-21%]) experienced BV recurrence within 1 month of treatment. Women with an untreated RSP were more likely to experience recurrence than women with no RSP (P = .008) or an RSP who received treatment (P = .011). A higher abundance of Prevotella pretreatment (adjusted odds ratio [AOR], 1.35 [95% CI, 1.05-1.91]) and Gardnerella immediately posttreatment (AOR, 1.23 [95% CI, 1.03-1.49]) were associated with increased odds of BV recurrence.

CONCLUSIONS

Having specific Prevotella spp prior to recommended treatment and persistence of Gardnerella immediately posttreatment may contribute to the high rates of BV recurrence. Interventions that target these taxa are likely required to achieve sustained BV cure.

摘要

背景

细菌性阴道病(BV)是一种常见的阴道菌群失调,在接受一线抗生素治疗后常常复发。我们研究了阴道微生物群落组成是否与 BV 复发有关。

方法

我们分析了 121 名女性的样本和数据,这些女性参与了 3 项评估新型干预措施以改善 BV 治愈率的研究,包括同时治疗常规性伴侣(RSP)的抗生素。诊断为 BV 的女性接受一线抗生素治疗,并在治疗前和抗生素治疗结束后(即治疗后即刻)自行采集阴道拭子。对阴道样本进行 16S rRNA 基因测序。逻辑回归探索了治疗前和治疗后阴道微生物群落特征与 BV 复发之间的关联。

结果

16 名女性(13% [95%置信区间 {CI},8%-21%))在治疗后 1 个月内复发。未治疗 RSP 的女性比无 RSP(P =.008)或已治疗 RSP(P =.011)的女性更有可能复发。治疗前 Prevotella 丰度较高(调整优势比 [AOR],1.35 [95% CI,1.05-1.91])和治疗后即刻 Gardnerella 丰度较高(AOR,1.23 [95% CI,1.03-1.49])与 BV 复发的几率增加相关。

结论

在推荐治疗前存在特定的 Prevotella spp 和治疗后即刻 Gardnerella 持续存在可能是导致 BV 高复发率的原因。可能需要针对这些分类群的干预措施才能实现持续的 BV 治愈。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0384/10469350/a3c4288207dc/jiad261f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0384/10469350/a3c4288207dc/jiad261f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0384/10469350/a3c4288207dc/jiad261f1.jpg

相似文献

1
Prevotella and Gardnerella Are Associated With Treatment Failure Following First-line Antibiotics for Bacterial Vaginosis.普雷沃氏菌属和加德纳菌属与细菌性阴道病一线抗生素治疗失败相关。
J Infect Dis. 2023 Aug 31;228(5):646-656. doi: 10.1093/infdis/jiad261.
2
Sex is associated with the persistence of non-optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study.性行为与细菌性阴道病治疗后非最佳阴道微生物群的持续存在有关:一项前瞻性队列研究。
BJOG. 2021 Mar;128(4):756-767. doi: 10.1111/1471-0528.16430. Epub 2020 Aug 16.
3
A novel , , and standard that improves accuracy in quantifying bacterial burden in vaginal microbial communities.一种新颖的、标准化的方法,可提高阴道微生物群落中细菌负荷定量的准确性。
Front Cell Infect Microbiol. 2023 Jun 19;13:1198113. doi: 10.3389/fcimb.2023.1198113. eCollection 2023.
4
Microbial interactions among , and prior to incident bacterial vaginosis: protocol for a prospective, observational study.细菌性阴道病发病前、和之间的微生物相互作用:一项前瞻性观察性研究的方案。 你提供的原文中“Microbial interactions among ”后面似乎有缺失内容,请你检查一下以便我能更准确翻译。
BMJ Open. 2024 Feb 5;14(2):e083516. doi: 10.1136/bmjopen-2023-083516.
5
A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis.细菌性阴道病患者同时行男性伴侣治疗的前瞻性、开放性、初步研究。
mBio. 2021 Oct 26;12(5):e0232321. doi: 10.1128/mBio.02323-21. Epub 2021 Oct 19.
6
Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.口服甲硝唑治疗对阴道微生物群的影响及治疗失败的相关因素。
Am J Obstet Gynecol. 2020 Feb;222(2):157.e1-157.e13. doi: 10.1016/j.ajog.2019.08.008. Epub 2019 Aug 9.
7
Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.两性表面活性剂栓剂治疗细菌性阴道病生物膜:临床研究和微生物组分析。
Microbiome. 2017 Sep 13;5(1):119. doi: 10.1186/s40168-017-0326-y.
8
Single-Molecule Approach to 16S rRNA for Vaginal Microbiome Signatures in Response to Metronidazole Treatment.基于单分子 16S rRNA 技术的阴道微生物组特征研究,以探讨甲硝唑治疗的反应。
Microbiol Spectr. 2023 Jun 15;11(3):e0170622. doi: 10.1128/spectrum.01706-22. Epub 2023 May 18.
9
Inflammatory cytokine biomarkers of asymptomatic sexually transmitted infections and vaginal dysbiosis: a multicentre validation study.无症状性性传播感染和阴道微生态失调的炎症细胞因子生物标志物:一项多中心验证研究。
Sex Transm Infect. 2019 Feb;95(1):5-12. doi: 10.1136/sextrans-2017-053506. Epub 2018 Jul 17.
10
Vaginal abundance is associated with outcome in antibiotic treatment of bacterial vaginosis and capable of inhibiting .阴道分泌物丰度与细菌性阴道病抗生素治疗结局相关,并具有抑制作用。
Front Cell Infect Microbiol. 2022 Nov 22;12:1033431. doi: 10.3389/fcimb.2022.1033431. eCollection 2022.

引用本文的文献

1
Vaginal microbiota: different roles of lactobacilli and community instability in chronic vulvovaginal discomfort.阴道微生物群:乳酸杆菌的不同作用及群落不稳定在慢性外阴阴道不适中的影响
Front Cell Infect Microbiol. 2025 Aug 18;15:1636873. doi: 10.3389/fcimb.2025.1636873. eCollection 2025.
2
Vaginal pharmacomicrobiomics modulates risk of persistent and recurrent bacterial vaginosis.阴道药物微生物组学调节持续性和复发性细菌性阴道病的风险。
NPJ Biofilms Microbiomes. 2025 Jul 1;11(1):115. doi: 10.1038/s41522-025-00748-0.
3
When a sore throat turns into deadly multiple serous cavity effusions: the role of in rapidly progressing infection-a case report.

本文引用的文献

1
Sexual behavior shapes male genitourinary microbiome composition.性行为塑造男性泌尿生殖系统微生物组组成。
Cell Rep Med. 2023 Mar 21;4(3):100981. doi: 10.1016/j.xcrm.2023.100981.
2
Treatment Success Following Standard Antibiotic Treatment for Bacterial Vaginosis Is Not Associated With Pretreatment Genital Immune or Microbial Parameters.细菌性阴道病标准抗生素治疗后的治疗成功与治疗前的生殖器免疫或微生物参数无关。
Open Forum Infect Dis. 2023 Jan 7;10(1):ofad007. doi: 10.1093/ofid/ofad007. eCollection 2023 Jan.
3
bacterial vaginosis biofilm community manipulation using endolysin therapy.
当咽喉痛转变为致命的多发性浆膜腔积液时: 在快速进展性感染中的作用——病例报告
Front Med (Lausanne). 2025 Jan 29;12:1517389. doi: 10.3389/fmed.2025.1517389. eCollection 2025.
4
Unveiling the dark side of : a case of fatal pneumonia from a common probiotic.揭开……的阴暗面:一例由常见益生菌引起的致命肺炎病例 (注:原文中“Unveiling the dark side of :”这里“of”后面缺少具体内容)
Front Med (Lausanne). 2024 Dec 24;11:1382134. doi: 10.3389/fmed.2024.1382134. eCollection 2024.
5
Characteristics of Vaginal Microbiota of Women of Reproductive Age with Infections.患有感染的育龄期女性阴道微生物群的特征
Microorganisms. 2024 May 20;12(5):1030. doi: 10.3390/microorganisms12051030.
6
The Role of Species in Female Genital Tract Infections.物种在女性生殖道感染中的作用
Pathogens. 2024 Apr 28;13(5):364. doi: 10.3390/pathogens13050364.
7
The human vaginal microbiota: from clinical medicine to models to mechanisms.人类阴道微生物群:从临床医学到模型再到机制
Curr Opin Microbiol. 2024 Feb;77:102422. doi: 10.1016/j.mib.2023.102422. Epub 2024 Jan 11.
使用溶菌酶疗法对细菌性阴道病生物膜群落进行调控
Biofilm. 2022 Dec 29;5:100101. doi: 10.1016/j.bioflm.2022.100101. eCollection 2023 Dec.
4
Association of key species of vaginal bacteria of recurrent bacterial vaginosis patients before and after oral metronidazole therapy with short- and long-term clinical outcomes.口服甲硝唑治疗前后复发性细菌性阴道病患者阴道关键细菌与短期和长期临床结局的相关性。
PLoS One. 2022 Jul 28;17(7):e0272012. doi: 10.1371/journal.pone.0272012. eCollection 2022.
5
In vitro interactions within a biofilm containing three species found in bacterial vaginosis (BV) support the higher antimicrobial tolerance associated with BV recurrence.在细菌性阴道病(BV)中三种细菌组成的生物膜内的体外相互作用支持了与 BV 复发相关的更高的抗菌药物耐受。
J Antimicrob Chemother. 2022 Jul 28;77(8):2183-2190. doi: 10.1093/jac/dkac155.
6
Preclinical Data on the -Specific Endolysin PM-477 Indicate Its Potential to Improve the Treatment of Bacterial Vaginosis through Enhanced Biofilm Removal and Avoidance of Resistance.关于 - 特异性内切酶 PM-477 的临床前数据表明,它有可能通过增强生物膜清除和避免耐药性来改善细菌性阴道病的治疗。
Antimicrob Agents Chemother. 2022 May 17;66(5):e0231921. doi: 10.1128/aac.02319-21. Epub 2022 Apr 13.
7
Metronidazole treatment rapidly reduces genital inflammation through effects on bacterial vaginosis-associated bacteria rather than lactobacilli.甲硝唑治疗通过对细菌性阴道病相关细菌而不是乳杆菌的作用,迅速减轻生殖器炎症。
J Clin Invest. 2022 Mar 15;132(6). doi: 10.1172/JCI152930.
8
Sialidase Activity in the Cervicovaginal Fluid Is Associated With Changes in Bacterial Components of -Deprived Microbiota.唾液酸酶活性与剥夺微生物群细菌成分的变化有关。
Front Cell Infect Microbiol. 2022 Jan 13;11:813520. doi: 10.3389/fcimb.2021.813520. eCollection 2021.
9
A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis.细菌性阴道病患者同时行男性伴侣治疗的前瞻性、开放性、初步研究。
mBio. 2021 Oct 26;12(5):e0232321. doi: 10.1128/mBio.02323-21. Epub 2021 Oct 19.
10
Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis.经甲硝唑治疗后反复发作的细菌性阴道病与诊断时的微生物丰富度相关。
Am J Obstet Gynecol. 2022 Feb;226(2):225.e1-225.e15. doi: 10.1016/j.ajog.2021.09.018. Epub 2021 Sep 22.